🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 30/05/2002 | 53,82 | 54,51 | 53,53 | 53,81 | -1,30% | 1,83% | 4.531.447 |
| 29/05/2002 | 53,47 | 54,58 | 53,39 | 54,51 | +1,95% | 2,23% | 6.305.921 |
| 28/05/2002 | 53,91 | 54,03 | 53,39 | 53,47 | -0,80% | 1,19% | 4.641.592 |
| 24/05/2002 | 54,82 | 55,25 | 53,69 | 53,90 | -1,76% | 2,84% | 4.125.662 |
| 23/05/2002 | 54,66 | 54,91 | 53,91 | 54,87 | -0,03% | 1,83% | 5.864.084 |
| 22/05/2002 | 55,06 | 55,58 | 54,41 | 54,89 | -0,48% | 2,13% | 4.425.390 |
| 21/05/2002 | 55,54 | 55,86 | 54,89 | 55,15 | -0,69% | 1,75% | 5.210.237 |
| 20/05/2002 | 55,37 | 56,15 | 54,97 | 55,53 | +0,12% | 2,14% | 5.167.688 |
| 17/05/2002 | 54,01 | 55,58 | 53,96 | 55,47 | +2,70% | 3,00% | 6.409.673 |
| 16/05/2002 | 54,29 | 54,30 | 53,44 | 54,01 | -0,53% | 1,60% | 6.015.834 |
| 15/05/2002 | 54,48 | 54,81 | 53,82 | 54,29 | -1,04% | 1,82% | 5.616.756 |
| 14/05/2002 | 54,37 | 55,14 | 54,27 | 54,87 | +1,52% | 1,60% | 5.767.773 |
| 13/05/2002 | 53,43 | 54,19 | 53,32 | 54,05 | +1,85% | 1,63% | 4.385.146 |
| 10/05/2002 | 53,23 | 54,36 | 52,84 | 53,06 | -0,27% | 2,85% | 6.027.886 |
| 09/05/2002 | 53,34 | 53,80 | 53,21 | 53,21 | -1,54% | 1,11% | 4.820.590 |
| 08/05/2002 | 52,72 | 54,36 | 52,29 | 54,04 | +1,94% | 3,93% | 5.606.695 |
| 07/05/2002 | 53,36 | 53,50 | 52,50 | 53,01 | -0,57% | 1,88% | 6.955.890 |
| 06/05/2002 | 53,05 | 53,72 | 52,97 | 53,31 | +0,67% | 1,42% | 6.422.039 |
| 03/05/2002 | 53,29 | 53,33 | 52,48 | 52,96 | -0,13% | 1,59% | 5.123.462 |
| 02/05/2002 | 52,77 | 53,24 | 52,19 | 53,02 | +0,49% | 1,99% | 7.489.951 |
| 01/05/2002 | 51,57 | 52,96 | 51,54 | 52,77 | +1,77% | 2,76% | 6.713.593 |
| 30/04/2002 | 52,00 | 52,19 | 51,29 | 51,85 | -0,60% | 1,72% | 7.758.030 |
| 29/04/2002 | 51,98 | 52,60 | 51,72 | 52,17 | +0,37% | 1,69% | 6.807.494 |
| 26/04/2002 | 52,58 | 52,58 | 51,31 | 51,98 | -0,77% | 2,41% | 4.980.306 |
| 25/04/2002 | 52,33 | 53,15 | 52,09 | 52,38 | +0,09% | 2,02% | 7.434.722 |
| 24/04/2002 | 52,77 | 53,14 | 52,10 | 52,33 | -1,17% | 1,97% | 6.776.787 |
| 23/04/2002 | 54,01 | 54,34 | 52,73 | 52,95 | -1,82% | 2,99% | 7.531.242 |
| 22/04/2002 | 54,34 | 54,38 | 53,67 | 53,93 | -0,74% | 1,30% | 5.781.816 |
| 19/04/2002 | 54,52 | 54,52 | 54,21 | 54,33 | +0,65% | 0,58% | 8.296.911 |
| 18/04/2002 | 53,44 | 54,15 | 53,24 | 53,98 | +2,76% | 1,70% | 10.308.966 |